The Scottish inflammatory prognostic score (SIPS), a novel and straightforward inflammatory score that combines albumin (ALB) and NEU, was recently proposed and has shown to be a more accurate predictor in non-small-cell lung cancer (NSCLC) patients receiving first-line ICIs (18). The gene discussed is ALB; the disease is non-small cell lung carcinoma.